128 related articles for article (PubMed ID: 7019638)
1. Triple drug chemotherapy for advanced ovarian carcinoma: comparative study of two regimens.
Aroney RS; Levi JA; Dalley DN
Med J Aust; 1981 Jun; 1(12):633-5. PubMed ID: 7019638
[TBL] [Abstract][Full Text] [Related]
2. A controlled clinical trial in advanced ovarian cancer.
Adams M; Johansen KA; James KW; Rocker I
Clin Radiol; 1982 Mar; 33(2):161-3. PubMed ID: 7039940
[TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).
Carmo-Pereira J; Costa FO; Henriques E; Ricardo JA
Cancer; 1981 Nov; 48(9):1947-51. PubMed ID: 6271386
[TBL] [Abstract][Full Text] [Related]
4. Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
de Palo GM; de Lena M; Di Re F; Luciani L; Valagussa P; Bonadonna G
Surg Gynecol Obstet; 1975 Dec; 141(6):899-902. PubMed ID: 1103333
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
6. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Bennett JM; Byrne P; Desai A; White C; DeConti R; Vogel C; Krementz E; Muggia F; Doroshow J; Plotkin D
Invest New Drugs; 1985; 3(2):179-85. PubMed ID: 3894279
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
Bull JM; Tormey DC; Li SH; Carbone PP; Falkson G; Blom J; Perlin E; Simon R
Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
10. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
[TBL] [Abstract][Full Text] [Related]
11. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
12. Second trial drugs in ovarian cancer.
Stanhope CR; Smith JP; Rutledge F
Gynecol Oncol; 1977 Mar; 5(1):52-8. PubMed ID: 404216
[No Abstract] [Full Text] [Related]
13. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
De Palo GM; De Lena M; Bonadonna G
Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
[No Abstract] [Full Text] [Related]
14. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
[TBL] [Abstract][Full Text] [Related]
15. Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():169-72. PubMed ID: 825778
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma.
Omura GA; Morrow CP; Blessing JA; Miller A; Buchsbaum HJ; Homesley HD; Leone L
Cancer; 1983 Mar; 51(5):783-9. PubMed ID: 6401594
[TBL] [Abstract][Full Text] [Related]
18. Adriamycin, BCNU, and cyclophosphamide in drug-resistant adenocarcinoma of the ovary.
Presant CA; Bartolucci A
Med Pediatr Oncol; 1983; 11(3):151-3. PubMed ID: 6682929
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
Dalley DN; Levi JA; Aroney RS
Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Vriesendorp R; Kooyman CD; van Lindert AC; Hamerlynck JV; van Lent M; van Houwelingen JC
Lancet; 1984 Sep; 2(8403):594-600. PubMed ID: 6147640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
